5 programs we will not list
All 5 would pay us to send readers their way. None of them is on the chart. The largest pays $350 a sale.
A new program passes six checks before it gets a chart row or a visit link.
- Transparent ownership. A named founder or chief executive, one legal entity, a real published address.
- Company age. The company or its domain is older than six months.
- Real user base. Review volume we can verify elsewhere, not a self-reported customer count.
- Clean reputation. No unresolved action over product safety or quality, no FTC action, no lawsuit over patient harm.
- No sibling brand marketing an unapproved drug. The check covers every brand under the same owners, not only the one applying.
- Verified first-party pricing. The price we would publish is readable on the program's own page.
| Program | Checks it failed | Why | What would change our mind |
|---|---|---|---|
| Oak Weight Loss |
| One set of terms names three different legal entities. The address is a placeholder and no founder, chief executive or medical director is named on the site. A sibling brand, RetaClinic, markets retatrutide, which the FDA has not approved for any use. | One legal entity with a real published address, named leadership, the compounding pharmacies disclosed, and no retatrutide sibling. |
| Trimi |
| No legal entity and no address are published. The site names medical directors but no owner. Its Trustpilot score fell from 4.6 to about 2.8 across 2026 on a run of refund and account-closure complaints. | An entity, an address and a named founder published, and the complaint pattern resolved. |
| Pallas Health |
| The domain was about four and a half months old when we looked, under our six-month floor. We found no review footprint outside the company's own site. | Age clears about October 7, 2026. It also needs a review footprint we can verify. |
| SnagRX |
| The 125,000-customer figure is the company's own. The only review footprint we could verify belongs to Embody, a sibling brand. No founder, chief executive or medical director is named, and the pricing page runs countdown timers. | A review footprint of its own plus a named leader on the site. |
| HealSend | Declined before the checks were run. The eligibility marketing settled it. | The listing says HealSend evaluates eligible patients starting at a BMI of 20 and sells that as more accessible than competing clinics. A BMI of 20 is a healthy weight. Its Awin listing opened eight days before we looked and has never paid a publisher. Its written terms promise about $100 a sale against an invitation promising $150 a lead. Contacts run across the company, an outside agency and a personal Gmail address. | Nothing on the current record. |
When a program fixes what its row names, we run the six checks again and it goes on the chart at whatever score it earns.
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.